By: Benzinga
UPDATE: JP Morgan Initiates DaVita HealthCare Partners at Overweight on Growth Outlook
JP Morgan initiated coverage on DaVita HealthCare Partners (NYSE: DVA ) with an Overweight rating and a $125 price target. JP Morgan said, "By combining the steady growth and cash generation of the company's core dialysis business with the best physician
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here